Clinical Trial Update: Triheptanoin for Children With Primary-Specific Pyruvate Dehydrogenase Complex (PDC) Deficiency [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and dosing of triheptanoin in children with pyruvate dehydrogenase complex deficiency, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyruvate Dehydrogenase Complex Deficiency

Drugs mentioned

• Triheptanoin (triheptanoin)

Snippet

Sponsor: Jirair Krikor Bedoyan | Conditions: Pyruvate Dehydrogenase Complex Deficiency | Phase 1 | Status: RECRUITING